Validation and potential refinement of the Malaysia Medication Adherence Assessment Tool (MyMAAT) among patients with non-dialysis chronic kidney disease.

ABSTRACT:

Background

Medication adherence is essential for managing chronic kidney disease (CKD) and preventing its progression. In Malaysia, adherence is commonly assessed using the 12-item Likert scale Malaysia Medication Adherence Assessment Tool (MyMAAT-12), but it has not been validated for CKD patients. Thus, this study aimed to validate and explore its potential for item reduction among non-dialysis CKD patients.

Methods and findings

A cross-sectional, multi-center study was conducted across eight health facilities in Pahang state from December 2023 to August 2024. Non-dialysis CKD patients aged 18 years and above, with or without diabetes, attending outpatient clinics, were given the 12-item self-administered MyMAAT-12 and items from the Beliefs about Medicines Questionnaire (

SUBMITTER: Lim MC 

PROVIDER: S-EPMC12468750 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature